COMMUNIQUÉS West-GlobeNewswire

Oncolix, Inc., Announces Approval for Listing on OTC-QB
18/12/2017
HOUSTON, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Oncolix, Inc., (OTC PINK:ONCX) announced today that the Company has been given approval by the OTC Markets to be listed and traded on the OTC-QB effective at the opening of [...]
Flexion Therapeutics Enrolls First Patient in Study Evaluating the Pharmacokinetics and Safety of ZILRETTA™ (triamcinolone acetonide extended-release injectable suspension) in Osteoarthritis of the Shoulder and Hip
18/12/2017
BURLINGTON, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) announced today that it has enrolled the first patient in a clinical trial to evaluate the pharmacokinetics and safety of [...]
argenx announces closing of U.S. public offering for gross proceeds of approximately $266 million
18/12/2017
Regulated information December 18, 2017 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX) a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based [...]
Zephyr Health’s Relationship Analytics Named a Top Innovative Product of 2017 by PM360
18/12/2017
SAN FRANCISCO, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Zephyr Health, the leading Insights-as-a-Service solution provider for Life Sciences companies, today announced that Zephyr Illuminate™ has been selected as one of the [...]
Harkesh Sandhu, MD is Honored by the American Health Council for “Best in Medicine”
18/12/2017
NEW YORK, Dec. 18, 2017 (GLOBE NEWSWIRE) -- The American Health Council is honored to name Harkesh Sandhu, MD as one of “America’s Best Doctors” for his unparalleled professional dedication and extraordinary [...]
Ossur Hf : Transactions in relation to share buyback program
18/12/2017
Announcement from Össur hf. No. 88/2017 Reykjavík, 18 December 2017 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]
Tauriga Sciences, Inc. and Ice + Jam LLC Confirm the Arrival of Commercial Grade “HerMan” Product Inventory from Manufacturer
18/12/2017
NEW YORK, NY, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG ) ("Tauriga" or the "Company"), engaged in building business through the development, distribution, and licensing of proprietary [...]
Orion Corporation: Managers' transactions - Huhta-Koivisto Eemeli
18/12/2017
ORION CORPORATION MANAGERS' TRANSACTIONS 18 DECEMBER 2017 at 17.15 EET Orion Corporation: Managers' transactions - Huhta-Koivisto Eemeli Orion Corporation has received the following disclosure under Market Abuse [...]
Emblem Corp. Launches Leading Line of Cannabis Oils to Meet Growing Demand and Drive Patient Acquisition
18/12/2017
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (EMC.WT) (“Emblem” or the “Company”) , one of the [...]
The Painful Side Effect to Gifting Gadgets this Holiday Season
18/12/2017
SCOTTSDALE, Ariz., Dec. 18, 2017 (GLOBE NEWSWIRE) -- If you have a new phone or the latest video game console wrapped beneath your tree, you may also be giving a painful gift to your loved ones this holiday season. Text [...]
The Painful Side Effect to Gifting Gadgets this Holiday Season
18/12/2017
ALBUQUERQUE, N.M., Dec. 18, 2017 (GLOBE NEWSWIRE) -- If you have a new phone or the latest video game console wrapped beneath your tree, you may also be giving a painful gift to your loved ones this holiday season. Text [...]
Coloplast acquires SAS Lilial
18/12/2017
Today Coloplast A/S acquires the French direct-to-consumer home delivery company SAS Lilial (Lilial) for a cash consideration of EUR 35.5m equal to approx. DKK 264m. Lilial is a privately owned, French direct-to [...]
Announcement no. 13/2017 - Coloplast A/S acquires SAS Lilial
18/12/2017
Coloplast A/S acquires SAS Lilial Coloplast A/S announced today that it has entered into a definitive agreement to acquire SAS Lilial (Lilial) for a cash consideration of EUR 35.5m equal to approx. DKK 264m on a cash [...]
Board of Olainfarm Will be Chaired by Olegs Grigorjevs
18/12/2017
Olaine, 2017-12-18 15:27 CET (GLOBE NEWSWIRE) -- Olegs Grigorjevs was Executive Director of AS Olainfarm and the Member of the Board with more than 20 years of experience in chemical and pharmaceutical sector. O. [...]
PCI Synthesis Identifies Trends Affecting the Generic Drugs Sector in 2018
18/12/2017
NEWBURYPORT, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. ( www.pcisynthesis.com ), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and [...]
Advantis Corp. Expects Quarterly Revenue Records Throughout 2018
18/12/2017
Newport Beach, CA , Dec. 18, 2017 (GLOBE NEWSWIRE) -- ADVANTIS CORPORATION (OTC PINK: ADVT ) CEO, Darren Cherry, took a moment to review the progress the company has made this year, and lays out an achievable set of [...]
Orion Corporation: Managers' transactions - Huhta-Koivisto Tero
18/12/2017
ORION CORPORATION MANAGERS' TRANSACTIONS 18 DECEMBER 2017 at 16.00 EET Orion Corporation: Managers' transactions - Huhta-Koivisto Tero Orion Corporation has received the following disclosure under Market Abuse [...]
La Jolla Pharmaceutical Company Announces Initiation of Multicenter, Randomized, Phase 2 Clinical Study of LJPC‑401 in Patients with Hereditary Hemochromatosis
18/12/2017
SAN DIEGO, Dec. 18, 2017 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (NASDAQ: LJPC ) (the Company or La Jolla) today announced the initiation of LJ401-HH01, a Phase 2 clinical study of LJPC‑401 (synthetic human [...]
athenahealth to Present at the 36th Annual J.P. Morgan Healthcare Conference
18/12/2017
WATERTOWN, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ: ATHN ), a leading provider of network-enabled services for hospital and ambulatory clients nationwide, today announced that Jonathan Bush, [...]

Pages